In addition to CXCL13, Sasagawa et al. [119] reported that the level of IL-10 in CSF is a superior biomarker for initial screening of patients with CNS lymphoma compared to CXCL13. The gene discussed is CXCL13; the disease is primary central nervous system lymphoma.